MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Matinas BioPharma Holdings Inc

Chiusa

0.52 4

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

0.5

Massimo

0.52

Dividendi

By Dow Jones

Utili prossimi

13 apr 2026

Matinas BioPharma Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 apr 2026, 23:17 UTC

Utili

Samsung Forecasts Record First-Quarter Operating Profit

6 apr 2026, 23:00 UTC

Azioni calde

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr 2026, 22:13 UTC

I principali Market Mover

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr 2026, 21:46 UTC

Acquisizioni, Fusioni, Takeovers

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr 2026, 17:09 UTC

I principali Market Mover

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr 2026, 16:56 UTC

Principali Notizie su Eventi

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr 2026, 14:47 UTC

I principali Market Mover

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr 2026, 00:00 UTC

Principali Notizie su Eventi

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr 2026, 23:58 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr 2026, 23:50 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr 2026, 23:36 UTC

Discorsi di Mercato

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr 2026, 23:15 UTC

Discorsi di Mercato

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr 2026, 22:52 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

6 apr 2026, 22:52 UTC

Discorsi di Mercato

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr 2026, 22:14 UTC

Discorsi di Mercato

Correction to Live Cattle Futures Article

6 apr 2026, 20:56 UTC

Discorsi di Mercato

Mexican Private Consumption Fell in January -- Market Talk

6 apr 2026, 20:50 UTC

Discorsi di Mercato

Energy & Utilities Roundup: Market Talk

6 apr 2026, 20:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

6 apr 2026, 19:58 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

6 apr 2026, 19:58 UTC

Discorsi di Mercato

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr 2026, 19:11 UTC

Discorsi di Mercato

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr 2026, 19:06 UTC

Discorsi di Mercato

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr 2026, 19:03 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

6 apr 2026, 19:03 UTC

Discorsi di Mercato

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr 2026, 18:36 UTC

Acquisizioni, Fusioni, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr 2026, 17:59 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr 2026, 17:13 UTC

Acquisizioni, Fusioni, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr 2026, 16:33 UTC

Discorsi di Mercato

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr 2026, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

6 apr 2026, 14:59 UTC

Utili

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Confronto tra pari

Modifica del prezzo

Matinas BioPharma Holdings Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

$

help-icon Live chat